Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04921917 · ClinicalTrials.gov registry record · NA

Exercise and Soft Tissue Sarcoma

A NA study of Soft Tissue Sarcoma, sponsored by Duke University.

Recruiting
Registry status
NA
Development phase
24
Enrollment target
1
Study location

NCT04921917 is a NA study of Soft Tissue Sarcoma that is actively recruiting participants, run by Duke University. The registered enrollment target is 24 participants, below the 79-participant average among 55 other Soft Tissue Sarcoma trials with a reported enrollment target (70% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04921917, a NA study of Soft Tissue Sarcoma, is actively recruiting participants, sponsored by Duke University.

RECRUITING
Registry status
NA
Development phase
24 participants
Enrollment target
1
Study location

Study Summary

The purpose of this study is to evaluate the effect of a neoadjuvant (i.e. pre-treatment) exercise regimen on extremity function and postoperative wound healing. The study group will include patients with a primary diagnosis of soft tissue sarcoma undergoing treatment with neoadjuvant radiation therapy and surgical resection. Patients with upper or lower extremity sarcomas will be considered for enrollment.

Conditions Studied

Interventions

  • OTHER neoadjuvant exercise therapy

Study Locations (1)

North Carolina

  • Duke University - Durham

Trial Details

FieldValue
Enrollment Target 24 participants
Start Date 2021-04-30
Est. Completion 2030-01-01
Phase NA

Sponsor

Duke University

1,725 total trials

What the Registry Record Tells You About NCT04921917

The ClinicalTrials.gov registry entry for NCT04921917 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 24 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 79-participant average among 55 other Soft Tissue Sarcoma trials with a reported enrollment target (70% lower). The listed sponsor is Duke University, which has 1,725 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Soft Tissue Sarcoma appearing as the primary indexed condition, and to 1 intervention - of which neoadjuvant exercise therapy is the first listed.

NCT04921917 reports 1 study location spanning 1 distinct geographic area - top geographies include North Carolina.

Frequently Asked Questions

What is clinical trial NCT04921917 about?

NCT04921917 is a clinical study titled "Exercise and Soft Tissue Sarcoma". The purpose of this study is to evaluate the effect of a neoadjuvant (i.e. pre-treatment) exercise regimen on extremity function and postoperative wound healing. The study group will include patients with a primary diagnosis of soft tissue sarcoma undergoing treatment with neoadjuvant radiation ther...

What is the current status of trial NCT04921917?

This trial is currently recruiting. It is a NA study. The enrollment target is 24 participants. The study started on 2021-04-30. Estimated completion is 2030-01-01.

What conditions does trial NCT04921917 study?

This clinical trial studies the following conditions: Soft Tissue Sarcoma.

What interventions are being tested in trial NCT04921917?

The interventions under investigation include: neoadjuvant exercise therapy (OTHER).

Who is sponsoring clinical trial NCT04921917?

This trial is sponsored by Duke University, which has 1,725 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT04921917 being conducted?

This trial has 1 study location across North Carolina. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Soft Tissue Sarcoma

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.